Skip to content

PD-L1 IHC 28-8 pharmDx SK005Recalls & reported problems

Agilent Technologies, Inc. · PD-L1 IHC 28-8 pharmDx · Class 3

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05700571108161), received between Dec 22, 2020 and Dec 22, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 22, 2020Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    CUSTOMER COMPLAINT RECORD REPORTED THE EVENT AS FOLLOWS: HEAVY STAINING IN POSITIVE TISSUES AND CONTROLS. CUSTOMER REQUESTED A DIFFERENT LOT FROM THE MANUFACTURER. NO DIRECT OR INDIRECT PATIENT HARM OR USER HARM HAVE BEEN REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11060445 ↗

Other Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 devices

All Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page